Bruce Wigley, RPH | |
1755 Lincolnway E, Goshen, IN 46526-6425 | |
(574) 533-4932 | |
Not Available |
Full Name | Bruce Wigley |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1755 Lincolnway E, Goshen, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326344334 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 26015072A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bruce Wigley, RPH 625 Amberwood Dr, Goshen, IN 46526-5529 Ph: (574) 534-3160 | Bruce Wigley, RPH 1755 Lincolnway E, Goshen, IN 46526-6425 Ph: (574) 533-4932 |
News Archive
In addition to its damaging effect on the environment and its illegal smuggling into developing countries, researchers have now linked e-waste to adverse effects on human health, such as inflammation and oxidative stress - precursors to cardiovascular disease, DNA damage and possibly cancer.
Advantage Capital Partners, a leading venture capital and small business finance firm, has provided $3.15 million in financing to Current Solutions, LLC, a wholesale distributor of electrotherapy devices and accessories to medical supply organizations throughout the United States and Canada. The funding, made in connection with the Texas Certified Capital Company (CAPCO) program, enabled Current Solutions to acquire Koalaty Products, Inc. and will support the company's move from Tampa, Fla. to Austin, Texas.
Researchers at Umeå University have developed a model that uses seasonal weather data from satellite images to accurately predict outbreak of malaria with a one-month lead time.
Medical interns spend just 12 percent of their time examining and talking with patients, and more than 40 percent of their time behind a computer, according to a new Johns Hopkins study that closely followed first-year residents at Baltimore's two large academic medical centers.
Oncolytics Biotech Inc. today announced preliminary results from a U.S. Phase 2 clinical trial (REO 017) using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar®) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC).
› Verified 6 days ago
Gary Nephew, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2824 Elkhart Rd, Goshen, IN 46526 Phone: 574-537-1111 | |
Mrs. Jennifer Cass, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3938 Midway Rd, Goshen, IN 46526 Phone: 574-875-0610 Fax: 574-875-0610 | |
Mr. David Rippey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 429 W Pike St, Goshen, IN 46526 Phone: 574-534-7616 | |
Jeremy Ray Kauffman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4522 Elkhart Rd, Goshen, IN 46526 Phone: 574-875-3010 Fax: 574-875-3065 | |
Katherine Staltari, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1527 Bashor Rd, Goshen, IN 46528 Phone: 574-533-5600 | |
David L Barhydt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4430 Elkhart Rd, Goshen, IN 46526 Phone: 574-875-0236 | |
Jodi Lynn Hicks I, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4522 Elkhart Rd, Goshen, IN 46526 Phone: 574-875-3010 Fax: 574-875-3065 |